CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens
Related Experiment Video
Updated: Sep 2, 2025

Application of CRISPR Interference CRISPRi for Gene Silencing in Pathogenic Species of Leptospira
Published on: August 14, 2021
Ujjayani Saha1, Rashmi Gondi1, Amrita Patil1
1Symbiosis School of Biological Sciences, Symbiosis International (Deemed University), Symbiosis Knowledge Village, Lavale, Pune, Maharashtra, 412115, India.
Abstract:
The ESKAPE (Enterococcus spp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) isolates both from the clinical settings and food products are demonstrated to gain resistance to multiple antimicrobials. Therefore, the ESKAPE pathogens pose a serious threat to public health, which warrants specific attention to developing alternative novel therapeutics. The clustered regularly interspaced short palindromic repeats associated (CRISPR-Cas) system is one of the novel methods for managing antibiotic-resistant strains. Specific Cas nucleases can be programmed against bacterial genomic sequences to decrease bacterial resistance to antibiotics. Moreover, a few CRISPR-Cas nucleases have the ability to the sequence-specific killing of bacterial strains. However, some pathogens acquire antibiotic resistance due to the presence of the CRISPR-Cas system. In brief, there is a wide range of functional diversity of CRISPR-Cas systems in bacterial pathogens. Hence, to be an effective and safe infection treatment strategy, a comprehensive understanding of the role of CRISPR-Cas systems in modulating antibiotic resistance in ESKAPE pathogens is essential. The present review summarizes all the mechanisms by which CRISPR confers and prevents antibiotic resistance in ESKAPE. The review also emphasizes the relationship between CRISPR-Cas systems, biofilm formation, and antibiotic resistance in ESKAPE.
Insights
The ESKAPE pathogens are developing antimicrobial resistance. The CRISPR-Cas system
Area of Science:
- Microbiology
- Genetics
- Infectious Diseases
Background:
- ESKAPE pathogens (Enterococcus spp., Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.) exhibit increasing antimicrobial resistance.
- These multidrug-resistant pathogens pose a significant threat to public health, necessitating novel therapeutic strategies.
Purpose of the Study:
- To review the multifaceted roles of the clustered regularly interspaced short palindromic repeats (CRISPR)-Cas system in modulating antibiotic resistance within ESKAPE pathogens.
- To elucidate the mechanisms by which CRISPR-Cas influences antibiotic resistance and biofilm formation in these critical pathogens.
Main Methods:
- Literature review of studies investigating CRISPR-Cas systems in ESKAPE pathogens.
- Analysis of research on the interplay between CRISPR-Cas, antibiotic resistance, and biofilm formation.
Main Results:
- CRISPR-Cas systems can both confer and prevent antibiotic resistance in ESKAPE pathogens through diverse mechanisms.
- The presence of CRISPR-Cas can lead to acquired antibiotic resistance in some bacterial strains.
- CRISPR-Cas systems are linked to biofilm formation, which is often associated with increased antibiotic resistance.
Conclusions:
- A comprehensive understanding of CRISPR-Cas system functions is crucial for developing safe and effective treatments against antibiotic-resistant ESKAPE pathogens.
- Targeting or manipulating CRISPR-Cas systems presents a potential avenue for novel antimicrobial therapies.
Related Concept Videos
CRISPR/Cas9 Genome Editing
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
Development of Antibiotic Resistance
The Antiviral System of Bacteria and Archaea: CRISPR
CRISPR
Antibiotic Selection

